PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Tandem Diabetes Care, Inc. (TNDM)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US8753722037

CUSIP

875372203

Sector

Healthcare

IPO Date

Nov 14, 2013

Highlights

Market Cap

$2.25B

EPS (TTM)

-$1.94

Total Revenue (TTM)

$973.67M

Gross Profit (TTM)

$425.41M

EBITDA (TTM)

-$99.45M

Year Range

$21.85 - $53.69

Target Price

$51.00

Short %

16.32%

Short Ratio

4.35

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
TNDM vs. DXCM TNDM vs. VOO TNDM vs. SPY TNDM vs. IYW
Popular comparisons:
TNDM vs. DXCM TNDM vs. VOO TNDM vs. SPY TNDM vs. IYW

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Tandem Diabetes Care, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-19.95%
8.64%
TNDM (Tandem Diabetes Care, Inc.)
Benchmark (^GSPC)

Returns By Period

Tandem Diabetes Care, Inc. had a return of 15.18% year-to-date (YTD) and 23.67% in the last 12 months. Over the past 10 years, Tandem Diabetes Care, Inc. had an annualized return of -12.50%, while the S&P 500 had an annualized return of 11.10%, indicating that Tandem Diabetes Care, Inc. did not perform as well as the benchmark.


TNDM

YTD

15.18%

1M

22.25%

6M

-19.97%

1Y

23.67%

5Y*

-11.00%

10Y*

-12.50%

^GSPC (Benchmark)

YTD

24.66%

1M

0.49%

6M

8.64%

1Y

26.56%

5Y*

13.06%

10Y*

11.10%

Monthly Returns

The table below presents the monthly returns of TNDM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-22.92%16.80%32.97%3.61%39.63%-21.35%-8.22%17.63%-2.51%-26.03%-2.36%15.18%
2023-9.37%-11.98%13.25%-2.54%-34.34%-5.58%42.30%-21.65%-24.09%-16.71%16.99%46.15%-34.19%
2022-21.53%-4.64%3.25%-17.03%-29.34%-13.17%11.86%-30.92%4.61%17.35%-25.11%6.90%-70.14%
2021-3.17%3.60%-8.06%4.14%-7.08%14.06%11.57%3.22%6.43%14.20%-5.73%17.12%57.32%
202027.56%-1.81%-13.81%23.98%4.22%18.97%5.60%7.91%0.69%-3.96%-13.87%1.92%60.51%
201914.51%50.80%-3.16%-3.29%11.64%-5.89%-1.69%14.19%-18.57%4.41%12.10%-13.65%56.99%
201817.80%13.67%56.96%53.83%83.88%56.95%25.16%65.78%-6.24%-12.21%-2.10%3.12%1,508.90%
20179.30%2.13%-50.00%-20.61%-16.52%0.59%-39.75%74.27%-13.10%-66.16%8.10%-11.61%-89.02%
2016-23.71%-0.78%-2.57%27.78%-41.15%15.11%-12.07%7.54%7.43%-21.02%-59.50%-12.24%-81.80%
2015-3.23%-4.80%7.86%5.78%-9.59%-10.19%15.77%-8.53%-23.26%2.95%13.67%14.55%-7.01%
20140.31%-0.39%-14.21%-20.46%-7.57%0.12%-23.19%13.29%-5.16%19.67%-12.02%-10.12%-50.72%
201314.28%17.08%33.80%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TNDM is 61, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TNDM is 6161
Overall Rank
The Sharpe Ratio Rank of TNDM is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of TNDM is 6464
Sortino Ratio Rank
The Omega Ratio Rank of TNDM is 5959
Omega Ratio Rank
The Calmar Ratio Rank of TNDM is 6060
Calmar Ratio Rank
The Martin Ratio Rank of TNDM is 6161
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Tandem Diabetes Care, Inc. (TNDM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for TNDM, currently valued at 0.35, compared to the broader market-4.00-2.000.002.000.352.12
The chart of Sortino ratio for TNDM, currently valued at 1.06, compared to the broader market-4.00-2.000.002.004.001.062.83
The chart of Omega ratio for TNDM, currently valued at 1.12, compared to the broader market0.501.001.502.001.121.39
The chart of Calmar ratio for TNDM, currently valued at 0.26, compared to the broader market0.002.004.006.000.263.13
The chart of Martin ratio for TNDM, currently valued at 1.02, compared to the broader market0.0010.0020.001.0213.67
TNDM
^GSPC

The current Tandem Diabetes Care, Inc. Sharpe ratio is 0.35. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Tandem Diabetes Care, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JulyAugustSeptemberOctoberNovemberDecember
0.35
2.12
TNDM (Tandem Diabetes Care, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Tandem Diabetes Care, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-88.64%
-2.37%
TNDM (Tandem Diabetes Care, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Tandem Diabetes Care, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tandem Diabetes Care, Inc. was 99.25%, occurring on Nov 3, 2017. The portfolio has not yet recovered.

The current Tandem Diabetes Care, Inc. drawdown is 88.64%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.25%Jan 13, 2014962Nov 3, 2017
-8.83%Dec 6, 201310Dec 19, 20134Dec 26, 201314
-8.24%Nov 18, 20133Nov 20, 20135Nov 27, 20138
-1.92%Nov 29, 20131Nov 29, 20131Dec 2, 20132
-0.8%Dec 30, 20131Dec 30, 20131Dec 31, 20132

Volatility

Volatility Chart

The current Tandem Diabetes Care, Inc. volatility is 15.92%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%JulyAugustSeptemberOctoberNovemberDecember
15.92%
3.87%
TNDM (Tandem Diabetes Care, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Tandem Diabetes Care, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Tandem Diabetes Care, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab